For: | Yang J, Yan LN. Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol 2008; 14(41): 6289-6297 [PMID: 19009641 DOI: 10.3748/wjg.14.6289] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i41/6289.htm |
Number | Citing Articles |
1 |
L. Chiche, B. Menahem, L. Plard. Tumori cistici e non cistici biliari. EMC - AKOS - Trattato di Medicina 2013; 15(2): 1 doi: 10.1016/S1634-7358(13)64592-1
|
2 |
Ruimei Liu, Yueqiang Song, Rulin Hua, Shariq Ahmed, Yunxiao Xie, Cong Lai, Jialu Xu, Fuyuan Li, Ying Li, Zhiguang Li, Yinping Wang, Dekang Lv, Qiwei Li. Cell-Free DNA in Plasma Reveals Genomic Similarity Between Biliary Tract Inflammatory Lesion and Biliary Tract Cancer. Phenomics 2024; 4(4): 339 doi: 10.1007/s43657-024-00160-2
|
3 |
Brendan Boland, Amanda Kim, Nicholas Nissen, Steve Colquhoun. Cholangiocarcinoma: Aggressive Surgical Intervention Remains Justified. The American Surgeon™ 2012; 78(2): 157 doi: 10.1177/000313481207800231
|
4 |
Sean P. Cleary, Jennifer Knox, Laura Ann Dawson. Gastrointestinal Oncology. 2011; : 251 doi: 10.1007/978-3-642-13306-0_10
|
5 |
Kazunori Tokuda, Yuji Morine, Yu Saito, Shinichiro Yamada, Katsuki Miyazaki, Shoko Yamashita, Shohei Okikawa, Tetsuya Ikemoto, Satoru Imura, Mitsuo Shimada. Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma. International Journal of Clinical Oncology 2020; 25(12): 2083 doi: 10.1007/s10147-020-01775-x
|
6 |
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 321 doi: 10.1016/bs.acr.2020.10.005
|
7 |
Dong Kuang, Guo-Ping Wang. Hilar cholangiocarcinoma: Pathology and tumor biology. Frontiers of Medicine in China 2010; 4(4): 371 doi: 10.1007/s11684-010-0130-6
|
8 |
Jonathan G. Navarro, Jin Ho Lee, Incheon Kang, Seoung Yoon Rho, Gi Hong Choi, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi. Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection?. HPB 2020; 22(10): 1411 doi: 10.1016/j.hpb.2020.01.009
|
9 |
Tuck Leong Yong, Nezor Houli, Chris Christophi. Anatomy of hepatic lymphatics and its implications in hepatic malignancies. ANZ Journal of Surgery 2016; 86(11): 868 doi: 10.1111/ans.13662
|
10 |
Eleni Gkika, Maria A. Hawkins, Anca-Ligia Grosu, Thomas B. Brunner. The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.604387
|
11 |
Kenya Yamanaka, Etsuro Hatano, Masashi Kanai, Shiro Tanaka, Keiichi Yamamoto, Masato Narita, Hiromitsu Nagata, Takamichi Ishii, Takahumi Machimoto, Kojiro Taura, Shinji Uemoto. A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer. International Journal of Clinical Oncology 2014; 19(3): 485 doi: 10.1007/s10147-013-0578-x
|
12 |
Ali Yousaf, Jin U. Kim, Joseph Eliahoo, Simon D. Taylor-Robinson, Shahid A. Khan. Ablative Therapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Journal of Clinical and Experimental Hepatology 2019; 9(6): 740 doi: 10.1016/j.jceh.2019.08.001
|
13 |
Sheng Hu, Chuqi Xia, Hao Zou, Wenjun Ren, Lixin Liu, Lianmin Wang, Qiang Kang, Kai He, Tao Wang, Xiaowen Zhang. HS6ST1 overexpressed in cancer-associated fibroblast and inhibited cholangiocarcinoma progression. Digestive and Liver Disease 2023; 55(8): 1114 doi: 10.1016/j.dld.2022.12.007
|
14 |
B. N. Gurmikov, Yu. A. Kovalenko, V. A. Vishnevsky, A. V. Chzhao. Intrahepatic cholangiocellular carcinoma: diagnosis and treatment (review). Annaly khirurgicheskoy gepatologii = Annals of HPB surgery 2019; 23(4): 108 doi: 10.16931/1995-5464.20184108-117
|
15 |
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: Update and future perspectives. Digestive and Liver Disease 2010; 42(4): 253 doi: 10.1016/j.dld.2009.12.008
|
16 |
Eunmi Gil, Jae-Won Joh, Hee Chul Park, Jeong Il Yu, Sang Hoon Jung, Jong Man Kim. Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study. World Journal of Surgical Oncology 2015; 13(1) doi: 10.1186/s12957-015-0637-z
|
17 |
Joo Hyun Lee, Ju-Hee Oh, Young-Joo Lee. Biliary Excretion of Curcumin Is Mediated by Multidrug Resistance-Associated Protein 2. Biological and Pharmaceutical Bulletin 2012; 35(5): 777 doi: 10.1248/bpb.35.777
|
18 |
Charbel Elias, Youssef H. Zeidan, Youssef Bouferraa, Deborah Mukherji, Sally Temraz, Maya Charafeddine, Monita Al Darazi, Ali Shamseddine. A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO). BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10373-1
|
19 |
U. Bork, M. Koch, M.W. Büchler, J. Weitz. Hepatobiliäre Tumorchirurgie. Der Chirurg 2010; 81(2): 111 doi: 10.1007/s00104-009-1812-y
|
20 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_29-1
|
21 |
|
22 |
Larisa E Vasilieva, Stefanos I Papadhimitriou, Spyros P Dourakis. Modern diagnostic approaches to cholangiocarcinoma. Hepatobiliary & Pancreatic Diseases International 2012; 11(4): 349 doi: 10.1016/S1499-3872(12)60192-1
|
23 |
Thorsten O. Goetze, Wolf O. Bechstein, Ulli Simone Bankstahl, Tobias Keck, Alfred Königsrainer, Sven A. Lang, Claudia Pauligk, Pompiliu Piso, Arndt Vogel, Salah-Eddin Al-Batran. Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) – a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)– the AIO/ CALGP/ ACO- GAIN-trial –. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6610-4
|
24 |
Selim R. Butros, Anuradha Shenoy-Bhangle, Peter R. Mueller, Ronald S. Arellano. Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome. Clinical Imaging 2014; 38(4): 490 doi: 10.1016/j.clinimag.2014.01.013
|
25 |
QING-LIANG WANG, XIAO-JIE LI, KUN ZHAO, BO LIU, XIAO-MING YE. Synchronous double primary cancer - intrahepatic cholangiocarcinoma with bone metastases and thyroid carcinoma: A case report. Oncology Letters 2015; 10(6): 3799 doi: 10.3892/ol.2015.3822
|
26 |
Pavan Najran, Angela Lamarca, Damian Mullan, Mairéad G. McNamara, Thomas Westwood, Richard A. Hubner, Jeremy Lawrence, Prakash Manoharan, Jon Bell, Juan W. Valle. Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma. Current Oncology Reports 2017; 19(7) doi: 10.1007/s11912-017-0603-8
|
27 |
Juan C. Camacho, Nima Kokabi, Minzhi Xing, David M. Schuster, Hyun S. Kim. PET Response Criteria for Solid Tumors Predict Survival at Three Months After Intra-Arterial Resin-Based 90Yttrium Radioembolization Therapy for Unresectable Intrahepatic Cholangiocarcinoma. Clinical Nuclear Medicine 2014; 39(11): 944 doi: 10.1097/RLU.0000000000000557
|
28 |
Anna Muñoz, Laura Lladó, Emilio Ramos, Jaume Torras, Antoni Rafecas. Hemorragia digestiva como manifestación del colangiocarcinoma periférico intraductal. Cirugía Española 2011; 89(1): 58 doi: 10.1016/j.ciresp.2010.03.017
|
29 |
Suzanne C. Schiffman, Tiffany Metzger, Gregory Dubel, Tomas Andrasina, Ivan Kralj, Cliff Tatum, Kelly M. McMasters, Charles R. Scoggins, Robert C. G. Martin. Precision Hepatic Arterial Irinotecan Therapy in the Treatment of Unresectable Intrahepatic Cholangiocellular Carcinoma: Optimal Tolerance and Prolonged Overall Survival. Annals of Surgical Oncology 2011; 18(2): 431 doi: 10.1245/s10434-010-1333-4
|
30 |
Shubhadip Chakrabarti, Ummity Srinivasa Rao. Lightweight neural network for smart diagnosis of cholangiocarcinoma using histopathological images. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-46152-6
|
31 |
Hanisah Guro, Jin Won Kim, YoungRok Choi, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han. Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approaches. Surgical Oncology 2017; 26(2): 146 doi: 10.1016/j.suronc.2017.03.001
|
32 |
B.N. Gurmikov, V.A. Vishnevsky, Yu.A. Kovalenko, A.V. Chzhao. Long-term results of surgical treatment of intrahepatic cholangiocarcinoma. Khirurgiya. Zhurnal im. N.I. Pirogova 2020; (5): 5 doi: 10.17116/hirurgia20200515
|
33 |
Billy James Uy, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho. Laparoscopic Liver Resection for Intrahepatic Cholangiocarcinoma. Journal of Laparoendoscopic & Advanced Surgical Techniques 2015; 25(4): 272 doi: 10.1089/lap.2014.0233
|
34 |
Giorgio Ercolani, Gaetano Vetrone, Gian Luca Grazi, Osamu Aramaki, Matteo Cescon, Matteo Ravaioli, Carla Serra, Giovanni Brandi, Antonio Daniele Pinna. Intrahepatic Cholangiocarcinoma. Annals of Surgery 2010; 252(1): 107 doi: 10.1097/SLA.0b013e3181e462e6
|
35 |
Maria E. Lozada, Ning Zhang, Weidong Jin, Nicha Wongjarupong, Ju Dong Yang, Molly M. Voss, Kritika Prasai, Dominic O. Amakye, William S. Harmsen, Sushant Chaudhary, Oliver F. Bathe, Mitesh J. Borad, Tushar C. Patel, Gregory J. Gores, Terry M. Therneau, Lewis R. Roberts. CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation. American Journal of Gastroenterology 2023; 118(12): 2173 doi: 10.14309/ajg.0000000000002258
|
36 |
Wei Yu, Chunxiu Hu, Yongjie Shui, Kui Wu, Lili Zhang, Ying Chen, Chao Li, Jing Xu, Qichun Wei. Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6328-3
|
37 |
Zeeshan Butt, Neehar D. Parikh, Jennifer L. Beaumont, Sarah K. Rosenbloom, Karen L. Syrjala, Amy P. Abernethy, Al B. Benson, David Cella. Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers. Cancer 2012; 118(23): 5997 doi: 10.1002/cncr.27588
|
38 |
Suzanne C. Schiffman, Michael R. Nowacki, Lena Spencer, Kelly M. McMasters, Charles R. Scoggins, Robert C.G. Martin. Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: A guide to adjuvant clinical trials. Journal of Surgical Oncology 2014; 109(2): 98 doi: 10.1002/jso.23459
|
39 |
Malek Kreidieh, Youssef H. Zeidan, Ali Shamseddine. The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/4304817
|
40 |
Kimberly M. Brown, Abhishek D. Parmar, David A. Geller. Intrahepatic Cholangiocarcinoma. Surgical Oncology Clinics of North America 2014; 23(2): 231 doi: 10.1016/j.soc.2013.10.004
|
41 |
Alexander Stein, Dirk Arnold, John Bridgewater, David Goldstein, Lars Henrik Jensen, Heinz-Josef Klümpen, Ansgar W. Lohse, Björn Nashan, John Primrose, Silke Schrum, Jenny Shannon, Eik Vettorazzi, Henning Wege. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1498-0
|
42 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 549 doi: 10.1007/978-3-319-26956-6_29
|
43 |
L. Chiche, B. Menahem, L. Plard. Tumeurs kystiques et non kystiques biliaires. EMC - Traité de médecine AKOS 2013; 8(1): 1 doi: 10.1016/S1634-6939(12)54655-7
|